BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 11339555)

  • 1. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
    Moffat JF; Zerboni L; Kinchington PR; Grose C; Kaneshima H; Arvin AM
    J Virol; 1998 Feb; 72(2):965-74. PubMed ID: 9444989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental infection of Cynomolgus Macaques (Macaca fascicularis) with human varicella-zoster virus.
    Willer DO; Ambagala AP; Pilon R; Chan JK; Fournier J; Brooks J; Sandstrom P; Macdonald KS
    J Virol; 2012 Apr; 86(7):3626-34. PubMed ID: 22258257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenesis and functional analysis of the varicella-zoster virus portal protein.
    Visalli MA; Nale Lovett DJ; Kornfeind EM; Herrington H; Xiao YT; Lee D; Plair P; Wilder SG; Garza BK; Young A; Visalli RJ
    J Virol; 2024 Apr; 98(4):e0060323. PubMed ID: 38517165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes zoster and the search for an effective vaccine.
    Arnold N; Messaoudi I
    Clin Exp Immunol; 2017 Jan; 187(1):82-92. PubMed ID: 27164323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enumeration of an extremely high particle-to-PFU ratio for Varicella-zoster virus.
    Carpenter JE; Henderson EP; Grose C
    J Virol; 2009 Jul; 83(13):6917-21. PubMed ID: 19369328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of the Oka vaccine strain of varicella-zoster virus.
    Yamanishi K
    J Infect Dis; 2008 Mar; 197 Suppl 2():S45-8. PubMed ID: 18419407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs.
    Heineman TC; Connelly BL; Bourne N; Stanberry LR; Cohen J
    J Virol; 1995 Dec; 69(12):8109-13. PubMed ID: 7494331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The varicella-zoster virus genome.
    Cohen JI
    Curr Top Microbiol Immunol; 2010; 342():1-14. PubMed ID: 20225013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus ORF47 protein kinase, which is required for replication in human T cells, and ORF66 protein kinase, which is expressed during latency, are dispensable for establishment of latency.
    Sato H; Pesnicak L; Cohen JI
    J Virol; 2003 Oct; 77(20):11180-5. PubMed ID: 14512565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro.
    Cohen JI; Seidel K
    J Virol; 1994 Dec; 68(12):7850-8. PubMed ID: 7966575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22.
    Heineman TC; Cohen JI
    J Virol; 1995 Nov; 69(11):7367-70. PubMed ID: 7474171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenesis of the varicella-zoster virus genome: lessons learned.
    Cohen JI
    Arch Virol Suppl; 2001; (17):91-7. PubMed ID: 11339555
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.